UK markets open in 7 hours 12 minutes

Unity Biotechnology, Inc. (UBX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.5200+0.0200 (+1.33%)
At close: 04:00PM EDT
1.5000 -0.02 (-1.32%)
After hours: 07:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-56,451
-39,860
-44,469
-60,725
-93,844
Depreciation & amortisation
2,442
1,182
2,180
2,880
3,449
Stock-based compensation
10,061
7,419
9,379
11,553
13,813
Change in working capital
-388
-4,391
-1,022
-631
-4,554
Accounts payable
671
-410
-194
-573
-2,640
Other working capital
-45,758
-37,099
-52,510
-45,255
-78,979
Other non-cash items
-1,117
-367
-818
943
420
Net cash provided by operating activities
-45,692
-37,088
-52,414
-45,060
-78,333
Cash flows from investing activities
Investments in property, plant and equipment
-66
-11
-96
-195
-646
Purchases of investments
-110,482
-28,609
-98,827
-81,492
-138,486
Sales/maturities of investments
95,000
89,000
74,000
121,000
133,924
Net cash used for investing activities
-15,276
60,495
-24,545
39,313
-5,208
Cash flows from financing activities
Debt repayment
-20,000
-20,000
0
-68
-405
Common stock issued
61,342
5,107
58,065
18,572
37,270
Other financing activities
-1,563
-1,563
-1,967
210
374
Net cash used provided by (used for) financing activities
61,550
-16,340
56,240
20,845
63,875
Net change in cash
582
7,067
-20,719
15,098
-19,666
Cash at beginning of period
23,440
13,632
34,351
19,253
38,919
Cash at end of period
24,022
20,699
13,632
34,351
19,253
Free cash flow
Operating cash flow
-45,692
-37,088
-52,414
-45,060
-78,333
Capital expenditure
-66
-11
-96
-195
-646
Free cash flow
-45,758
-37,099
-52,510
-45,255
-78,979